Literature DB >> 22797665

Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection.

Aaron W Puri1, Petr Broz, Aimee Shen, Denise M Monack, Matthew Bogyo.   

Abstract

Here we report AWP28, an activity-based probe that can be used to biochemically monitor caspase-1 activation in response to proinflammatory stimuli. Using AWP28, we show that apoptosis is triggered upon Salmonella enterica var. Typhimurium infection in primary mouse bone marrow macrophages lacking caspase-1. Furthermore, we report that upon Salmonella infection, inflammasome-mediated caspase-1 activity is required to bypass apoptosis in favor of proinflammatory pyroptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797665      PMCID: PMC3461347          DOI: 10.1038/nchembio.1023

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


The cysteine protease caspase-1 initiates a pro-inflammatory cell death program termed pyroptosis in response to a variety of insults including metabolic stress and bacterial infection[1-3]. Pyroptosis is characterized by rapid loss of membrane integrity, resulting in cell lysis and release of pro-inflammatory components. Unlike apoptosis, pyroptosis is not immunologically silent and is regulated by formation of an intracellular multi-protein complex called the inflammasome[1,3-5]. Inflammasomes contain cytosolic pattern recognition receptors (PRRs), the pro-inflammatory cysteine protease caspase-1, and often the adapter protein ASC[5]. These receptors oligomerize in response to pathogen-or danger-associated molecular patterns (PAMPs or DAMPs), triggering autoproteolytic activation of the procaspase-1 zymogen into its active, tetrameric form. Because caspases are activated post-translationally, activity-based probes (ABPs) are powerful tools for studying their regulation and function[6]. In order to biochemically characterize inflammasome-mediated caspase-1 activation, we synthesized the fluorescently labeled probe AWP28 (Supplementary Methods), which contains an acyloxymethyl ketone electrophile linked to an optimized scaffold for caspase-1 recognition[7] (Fig. 1a). When intact primary BMMs were infected with the Gram-negative intracellular bacterial pathogen Salmonella typhimurium, AWP28 primarily labeled multiple forms of caspase-1 as confirmed by immunoprecipitation (Fig. 1b,c). This included the p45 and p35 proforms[8], revealing that higher molecular-weight forms of caspase-1 are active in response to S. typhimurium infection before being processed to the final catalytic p20 subunit in the p20/p10 heterotetramer. Interestingly, AWP28 labeled the p35 form of caspase-1 to a greater extent than the p20 and p22 forms, despite reports that these smaller forms are up to 130 fold more active[8,9]. Importantly, AWP28 showed significantly reduced non-specific background labeling compared to the commercially available caspase-1 probe FLICA, which contains the highly reactive fluoromethyl ketone electrophile[10,11] (Supplementary Results, Supplementary Fig. 1). AWP28 also labeled a small amount of active executioner caspase-7 in response to S. typhimurium infection, consistent with its reported activation during pyroptosis[12].
Figure 1

AWP28 is an optimized caspase activity-based probe. (a) Structure of AWP28 (1). AWP28 labeling of intact primary murine bone marrow macrophages (BMMs) (b) infected with S. typhimurium (10:1) for 1 hour or (d) stimulated with 500 nM staurosporine for 4 hours. Cells were labeled with the indicated probe concentration for the final hour prior to harvest. Labeled proteins that are competed away upon pretreatment with 50 μM JPM-OEt (JPM) or 10 μM LI-1 reveal off-target lysosomal cysteine proteases (cathepsins and legumain, respectively). The identities of the labeled proteins as determined by immunopreciptiation in c and e are indicated with symbols that are defined in the key. (c,e) Labeled protein identification by immunoprecipitation. Stimulated BMMs were labeled with 1 μM AWP28 for the final hour, and subsequently labeled active caspases were immunoprecipitated using caspase-specific antibodies.

Because our caspase-1 probe was capable of labeling caspase-7, we wanted to determine if it could be used to visualize caspase activation upon initiation of classical apoptotic pathways. In BMMs undergoing staurosporine-induced intrinsic apoptosis, AWP28 labeled the executioner caspases-3 and -7, as confirmed by immunoprecipitation (Fig. 1d, e). Characterization by in vitro inhibition kinetics showed AWP28 is over 10-fold more potent against caspase-1 than other tested caspases (Supplementary Table 1), yet it can be used to simultaneously visualize activation of caspase-1 and downstream executioner caspases. AWP28 can also be used in microscopy to show co-localization of active caspase-1 with the adapter protein ASC, which oligomerizes into large macromolecular inflammasome foci that serve as an activating platform for procaspase-1[13] (Supplementary Fig. 2). We found that the fraction of AWP28 labeled ASC foci saturated at concentrations as low as 100 nM whereas FLICA showed much higher levels of background and failed to completely label all ASC foci even at the highest concentration tested (Supplementary Fig. 2b). Importantly, despite this level of potency, AWP28 does not inhibit downstream physiological events of infection such as cell death or IL-1β processing and release (Supplementary Fig. 3). We next used AWP28 to dissect the kinetics of caspase-1 activation upon Salmonella infection in macrophages lacking different components of the inflammasome complex. Active forms of caspase-1 could be detected by AWP28 for several hours following infection of wild type BMMs (Fig. 2a). This activity was lost over time because the active protease is secreted and the cells are dying via pyroptosis[14]. Surprisingly, when the probe was used to visualize caspase activation in Casp1−/− BMMs, robust activation of the executioner caspases-3 and -7 was observed (Fig. 2a, Supplementary Fig. 4). We also found that activation of the executioner caspases was significantly delayed in infected BMMs lacking the receptors for S. typhimurium, NLRP3 and NLRC4[13] compared to Casp1−/− cells. In contrast, when ASC deficient BMMs were infected with S. typhimurium, none of the caspases were robustly activated (Fig. 2a). These cells undergo pyroptosis similar to wild type BMMs, but do not produce detectable levels of cleaved caspase-1[15]. Activity of the p45 procaspase-1 has been shown to be essential for this cell death; however this activity appears to be below the detection limit of AWP28. S. typhimurium infected wild type and Asc−/− BMMs showed rapid release of LDH, which is a hallmark of pyroptosis[1-3] (Fig. 2b). In contrast, infected cells lacking caspase-1 or the inflammasome receptors released LDH at a much slower rate, consistent with a primarily apoptotic cell death. Together these results suggest that caspase-3 and -7 are activated in response to S. typhimurium infection in the absence of inflammasome-mediated caspase-1 activation.
Figure 2

S. typhimurium infection triggers apoptosis in the absence of inflammasome-mediated caspase-1 activation. (a) BMMs missing different inflammasome components as indicated were infected with S. typhimurium (10:1) and labeled with 1 μM AWP28 for one hour prior to each time point. The identities of the various labeled proteins are indicated with symbols that are defined in the key. (b) Cell death was measured by release of lactate dehydrogenase. Data represents the mean of 3 samples +/− one standard deviation. (c,d) BMMs were infected with S. typhimurium (10:1) for 2 hours. (c) Whole cell lysates were blotted for caspase-9 and cleaved caspase-3, -7, and cleaved poly (ADP-ribose) polymerase (PARP). β-actin serves as a loading control. Full blots are shown in Supplementary Fig. 8. (d) Cells were labeled with 1 μM AWP28 (green) for the last hour and stained with annexin V (blue) and propidium iodide (red). Uninfected and staurosporine controls are shown in Supplementary Fig. 9. Inflammasome focus is indicated with white arrowhead. Scale bars represent 5 μm.

We wanted to better characterize the cell death observed in the Casp1 and Nlrp3 genotypes. Activation of executioner caspases-3 and -7 in Salmonella infected macrophages correlated with cleavage of apoptotic initiator caspase-9 as well as with cleavage of the apoptotic executioner caspase substrate poly (ADP-ribose) polymerase (PARP; Fig. 2c). These cells also retained membrane integrity two hours post infection as shown by lack of propidium iodide (PI) staining, but were stained by annexin V indicating a loss of membrane asymmetry characteristic of early apoptosis (Fig. 2d). In contrast, both infected wild type and Asc BMMs were PI and annexin V positive due to membrane damage associated with pyroptosis[2]. Infected wild type cells also formed AWP28 labeled inflammasome foci (Fig. 2d). We did not detect cleaved caspase-3, -7, -9 or PARP in an equal amount of infected wild type BMMs undergoing pyroptosis (Fig. 2c). Taken together these results suggest that BMMs infected with Salmonella undergo apoptosis in the absence of inflammasome-mediated caspase-1 activation. This phenomenon was also observed upon infection with the Gram-negative coccobacillus Francisella novicida, consistent with recently published work[16] (Supplementary Fig. 5). We also examined mitochondrial cytochrome c release as a marker of apoptosis upon bacterial infection. Cytochrome c was detected in the cytosol of Casp1 BMMs and in a delayed manner in Nlrp3 cells infected with S. typhimurium (Supplementary Fig. 6). Surprisingly, cytochrome c was also released at rates as fast or faster in wild type and Asc macrophages, which undergo pyroptosis. Despite releasing cytochrome c, these pyroptotic cells were not able to effectively induce caspase-9 activation (Fig. 2c, Supplementary Fig. 5). Because active caspases are known to induce cytochrome c release[17], it is possible that cytochrome c released during pyroptosis happens at a late stage of death and is not productive for apoptosome formation. Because caspase-1 acts in a complex with other proteins, we wanted to determine if the presence of the protein alone was sufficient to block the apoptotic death observed in the casapse-1 deficient cells. Therefore, we infected immortalized Casp1−/− BMMs stably expressing active or catalytically dead (C284A) caspase-1[15] with S. typhimurium (Fig. 3a). We observed faint labeling of active caspase-3 and -7 by AWP28 in uninfected wild type and Casp1−/− control cells; however no significant background cytochrome c release was observed in these cells (Supplementary Fig. 7). Casp1−/− cells expressing wild type caspase-1 showed caspase-1 labeling by AWP28 upon infection and underwent pyroptosis with kinetics similar to immortalized wild type BMMs (Fig. 3a,b). However, expression of the catalytically dead mutant caspase-1 failed to block the robust activation of the apoptotic executioner caspases-3 and -7 seen in control Casp1−/− cells (Fig. 3a). Immortalized Casp1−/− BMMs expressing catalytically dead caspase-1 also retained markers of apoptosis including caspase-9 and PARP cleavage (Fig. 3c). Together these results indicate that caspase-1 proteolytic activity is required to bypass apoptosis in response to Salmonella infection. It was recently reported that Casp1 BMMs also lack caspase-11[18]. However, our ability to restore pyroptosis by expression of caspase-1 alone confirm that the interplay between apoptosis and pyroptosis is solely dependent on caspase-1 activity.
Figure 3

Caspase-1 activity is required to bypass apoptosis upon S. typhimurium infection. Immortalized BMMs (indicated by “i”) stably transfected with wild type or catalytically dead (C284A) caspase-1 were infected with S. typhimurium (10:1). (a) Time course of caspase activation. BMMs were labeled with 1 μM AWP28 for 1 hour prior to each time point. The identities of the various labeled proteins are indicated with symbols that are defined in the key. (b) Time course of S. typhimurium induced cell death as measured by LDH release. (c) Characterization of cell death by blotting whole cell lysates for caspase-9 and cleaved caspase-3,-7, and cleaved PARP. β-actin serves as a loading control. Full blots are shown in Supplementary Fig. 10.

In conclusion, we used the activity-based caspase probe AWP28 to show that intracellular bacterial pathogens trigger apoptosis in the absence of caspase-1 activation. Pyroptosis provides an effective mechanism for the clearance of intracellular bacteria[19]. This explains why many intracellular pathogens have evolved strategies to prevent inflammasome-mediated caspase-1 activation[20,21]. It would therefore be beneficial for the host to evolve a backup cell death pathway to destroy the replicative niche for intracellular pathogens capable of inhibiting pyroptosis. The bacterial PAMPs that transduce the pro-apoptotic signal are unknown. However, we show that apoptosis triggered by Salmonella infection is significantly delayed in the absence of the inflammasome receptors NLRP3 and NLRC4, suggesting possible overlap between pro-apoptotic and pro-pyroptotic signals (Fig. 2, Supplementary Fig. 6). In some instances pro-inflammatory stimuli have been reported to trigger apoptosis in the absence of caspase-1[16,22,23]. It is now clear from our results that caspase-1 activity is required to suppress apoptosis upon Salmonella infection. It has recently been shown that during embryogenesis and T-cell proliferation active pro-apoptotic caspase-8 blocks necroptosis by processing CYLD[24,25], which is consistent with our findings of cross-regulation of death pathways by caspase-1 activity. It is not yet clear if caspase-1 is directly cleaving a substrate that prevents the activation of the apoptotic cascade. The identification of specific points of feedback between pro-inflammatory and immunologically silent cell death programs may enable innate immune responses to be therapeutically modulated in pathologies such as auto-inflammatory diseases or cancer.
  24 in total

Review 1.  Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

2.  Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity.

Authors:  Alicia B Berger; Kelly B Sexton; Matthew Bogyo
Journal:  Cell Res       Date:  2006-12       Impact factor: 25.617

3.  All that glitters is not gold: all that FLICA binds is not caspase. A caution in data interpretation--and new opportunities.

Authors:  Zbigniew Darzynkiewicz; Piotr Pozarowski
Journal:  Cytometry A       Date:  2007-08       Impact factor: 4.355

4.  Caspases induce cytochrome c release from mitochondria by activating cytosolic factors.

Authors:  E Bossy-Wetzel; D R Green
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

5.  AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages.

Authors:  R Pierini; C Juruj; M Perret; C L Jones; P Mangeot; D S Weiss; T Henry
Journal:  Cell Death Differ       Date:  2012-05-04       Impact factor: 15.828

6.  Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme.

Authors:  T T Yamin; J M Ayala; D K Miller
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

7.  Mycobacterium tuberculosis prevents inflammasome activation.

Authors:  Sharon S Master; Silvana K Rampini; Alexander S Davis; Christine Keller; Stefan Ehlers; Burkhard Springer; Graham S Timmins; Peter Sander; Vojo Deretic
Journal:  Cell Host Microbe       Date:  2008-04-17       Impact factor: 21.023

8.  Active caspase-1 is a regulator of unconventional protein secretion.

Authors:  Martin Keller; Andreas Rüegg; Sabine Werner; Hans-Dietmar Beer
Journal:  Cell       Date:  2008-03-07       Impact factor: 41.582

9.  Salmonella-induced caspase-2 activation in macrophages: a novel mechanism in pathogen-mediated apoptosis.

Authors:  V Jesenberger; K J Procyk; J Yuan; S Reipert; M Baccarini
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

10.  (S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1beta and IL-18.

Authors:  Woods Wannamaker; Robert Davies; Mark Namchuk; John Pollard; Pamella Ford; George Ku; Caroline Decker; Paul Charifson; Peter Weber; Ursula A Germann; Keisuke Kuida; John C R Randle
Journal:  J Pharmacol Exp Ther       Date:  2007-02-08       Impact factor: 4.030

View more
  34 in total

1.  Labeling of active proteases in fresh-frozen tissues by topical application of quenched activity-based probes.

Authors:  Nimali P Withana; Megan Garland; Martijn Verdoes; Leslie O Ofori; Ehud Segal; Matthew Bogyo
Journal:  Nat Protoc       Date:  2015-12-30       Impact factor: 13.491

Review 2.  Converging roles of caspases in inflammasome activation, cell death and innate immunity.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Nat Rev Immunol       Date:  2015-12-14       Impact factor: 53.106

3.  Development of α-helical calpain probes by mimicking a natural protein-protein interaction.

Authors:  Hyunil Jo; Nataline Meinhardt; Yibing Wu; Swapnil Kulkarni; Xiaozhen Hu; Kristin E Low; Peter L Davies; William F DeGrado; Doron C Greenbaum
Journal:  J Am Chem Soc       Date:  2012-10-11       Impact factor: 15.419

Review 4.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

5.  Macrophage cell death upon intracellular bacterial infection.

Authors:  Xin-He Lai; Yunsheng Xu; Xiao-Ming Chen; Yi Ren
Journal:  Macrophage (Houst)       Date:  2015-04-26

6.  TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis.

Authors:  Sanna Nyström; Daniel J Antoine; Peter Lundbäck; John G Lock; Andreia F Nita; Kari Högstrand; Alf Grandien; Helena Erlandsson-Harris; Ulf Andersson; Steven E Applequist
Journal:  EMBO J       Date:  2012-12-07       Impact factor: 11.598

7.  A coupled protein and probe engineering approach for selective inhibition and activity-based probe labeling of the caspases.

Authors:  Junpeng Xiao; Petr Broz; Aaron W Puri; Edgar Deu; Montse Morell; Denise M Monack; Matthew Bogyo
Journal:  J Am Chem Soc       Date:  2013-06-06       Impact factor: 15.419

Review 8.  Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection.

Authors:  Youssef Aachoui; Vitaliya Sagulenko; Edward A Miao; Katryn J Stacey
Journal:  Curr Opin Microbiol       Date:  2013-05-23       Impact factor: 7.934

9.  K45A mutation of RIPK1 results in poor necroptosis and cytokine signaling in macrophages, which impacts inflammatory responses in vivo.

Authors:  B Shutinoski; N A Alturki; D Rijal; J Bertin; P J Gough; M G Schlossmacher; S Sad
Journal:  Cell Death Differ       Date:  2016-06-03       Impact factor: 15.828

Review 10.  Applications of small molecule probes in dissecting mechanisms of bacterial virulence and host responses.

Authors:  Aaron W Puri; Matthew Bogyo
Journal:  Biochemistry       Date:  2013-08-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.